Nabieh Ayoub
- Molecular Biology top 5%
- DNA Repair Mechanisms 19
- Genomics and Chromatin Dynamics 15
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 7
- RNA Research and Splicing 7
- CRISPR and Genetic Engineering 6
- Ubiquitin and proteasome pathways 4
- Aging top 10%
- Cancer Research top 10%
- Oncology top 10%
- PARP inhibition in cancer therapy 8
- Plant Science top 5%
- Co-authors
- Amikam CohenAnand D. JeyasekharanShiv I. S. GrewalKen-ichi NomaIra M. HallAshok R. VenkitaramanJuan A. BernalSamah W. Awwad
- Journals
- Nature (1 paper)Science (1 paper)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- IsraelUnited KingdomUnited States
In The Last Decade
Nabieh Ayoub
34 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Biology 2.1k
- Aging 31
- Cancer Research 184
- Oncology 326
- Plant Science 413
Countries citing papers authored by Nabieh Ayoub
This map shows the geographic impact of Nabieh Ayoub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabieh Ayoub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabieh Ayoub more than expected).
Fields of papers citing papers by Nabieh Ayoub
This network shows the impact of papers produced by Nabieh Ayoub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabieh Ayoub. The network helps show where Nabieh Ayoub may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nabieh Ayoub, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 12 | |
| 6 | 2022 | 26 | |
| 7 | 2021 | 25 | |
| 8 | 2020 | 50 | |
| 9 | 2017 | 63 | |
| 10 | 2014 | 28 | |
| 11 | 2014 | 34 | |
| 12 | 2013 | 30 | |
| 13 | 2012 | 52 | |
| 14 | 2009 | 78 | |
| 15 | 2009 | 26 | |
| 16 | 2008 | 338 | |
| 17 | Establishment and Maintenance of a Heterochromatin Domainbreakdown → | 2002 | 710 |
| 18 | 2000 | 49 | |
| 19 | 1999 | 41 | |
| 20 | 1997 | 62 |
About Nabieh Ayoub
Nabieh Ayoub is a scholar working on Molecular Biology, Oncology and Genetics, having authored 37 papers that have together received 2.2k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (19 papers), Genomics and Chromatin Dynamics (15 papers), PARP inhibition in cancer therapy (8 papers), Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (7 papers), RNA Research and Splicing (7 papers), CRISPR and Genetic Engineering (6 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Molecular Biology (2.1k citations), Aging (31 citations) and Cancer Research (184 citations). Nabieh Ayoub has collaborated with scholars based in Israel, United Kingdom and United States. Frequent co-authors include Amikam Cohen, Anand D. Jeyasekharan, Shiv I. S. Grewal, Ken-ichi Noma, Ira M. Hall, Ashok R. Venkitaraman, Juan A. Bernal, Samah W. Awwad, Noga Guttmann‐Raviv and Hanan Khoury-Haddad. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.